HIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.482200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.691050E-01
Normal-vs-Stage2
7.243000E-01
Normal-vs-Stage3
1.737620E-01
Normal-vs-Stage4
3.877200E-01
Stage1-vs-Stage2
6.550200E-02
Stage1-vs-Stage3
9.533600E-02
Stage1-vs-Stage4
2.305600E-02
Stage2-vs-Stage3
1.57439999926012E-08
Stage2-vs-Stage4
7.426400E-02
Stage3-vs-Stage4
4.964300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.667200E-01
Normal-vs-AfricanAmerican
6.223800E-01
Normal-vs-Asian
6.892000E-01
Caucasian-vs-AfricanAmerican
9.745900E-02
Caucasian-vs-Asian
9.301600E-01
AfricanAmerican-vs-Asian
2.697000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.143600E-01
Normal-vs-Female
7.017800E-01
Male-vs-Female
4.566800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.155000E-01
Normal-vs-Age(41-60Yrs)
9.891800E-01
Normal-vs-Age(61-80Yrs)
5.743800E-01
Normal-vs-Age(81-100Yrs)
9.992200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.744600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.655600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.475200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.930300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.231770E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.634630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.485800E-01
Normal-vs-Daily Drinker
3.386200E-01
Normal-vs-Weekly Drinker
9.771600E-01
Normal-vs-Occasional Drinker
8.722000E-01
Normal-vs-Social Drinker
9.947400E-01
Non Drinker-vs-Daily Drinker
6.840000E-01
Non Drinker-vs-Weekly Drinker
1.379750E-01
Non Drinker-vs-Occasional Drinker
3.099000E-01
Non Drinker-vs-Social Drinker
1.107040E-01
Daily Drinker-vs-Weekly Drinker
1.217450E-01
Daily Drinker-vs-Occasional Drinker
2.107800E-01
Daily Drinker-vs-Social Drinker
9.819800E-02
Weekly Drinker-vs-Occasional Drinker
8.076800E-01
Weekly Drinker-vs-Social Drinker
9.694400E-01
Occasional Drinker-vs-Social Drinker
7.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.408800E-01
Normal-vs-Grade 2
1.148400E-01
Normal-vs-Grade 3
1.191840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.158020E-02
Grade 1-vs-Grade 3
4.616500E-02
Grade 1-vs-Grade 4
4.408800E-01
Grade 2-vs-Grade 3
6.355600E-01
Grade 2-vs-Grade 4
1.148400E-01
Grade 3-vs-Grade 4
1.191840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.389200E-01
Normal-vs-NonDiabetic
5.955000E-01
Diabetic-vs-NonDiabetic
7.296400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.703200E-01
Normal-vs-NoPancreatitis
5.880400E-01
Pancreatitis-vs-NoPancreatitis
5.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.591800E-01
Normal-vs-N1
7.481000E-01
N0-vs-N1
1.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.529000E-01
Normal-vs-TP53-NonMutant
4.213400E-01
TP53-Mutant-vs-TP53-NonMutant
3.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
